رجوع
55
23
نطاق اليوم
KWD 9.42
KWD 9.59
نطاق 52 أسبوعًا
KWD 9.23
KWD 16.00
حجم التداول
4,258
متوسط 50 يوم / 200 يوم
KWD 10.93
/
KWD 11.40
الإغلاق السابق
KWD 9.27
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.2 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 7.8 | 3.8 |
| Net Margin % | 6.3 | 3.9 |
| Rev Growth 5Y % | 3.1 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
230 B | 0 |
| FY2026 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
230 B | 0 |
النقاط الرئيسية
Revenue grew 3.07% annually over 5 years — modest growth
Earnings declined -17.20% over the past year
Debt/Equity of 0.15 — conservative balance sheet
Generating 6.58B in free cash flow
P/E of 0.22 — trading at a low valuation
Capital efficient — spends only 3.86% of revenue on capex
النمو
Revenue Growth (5Y)
3.07%
Revenue (1Y)1.55%
Earnings (1Y)-17.20%
FCF Growth (3Y)N/A
الجودة
Return on Equity
7.82%
ROIC7.55%
Net Margin6.25%
Op. Margin9.19%
الأمان
Debt / Equity
0.15
Current Ratio2.53
Interest Coverage143.84
التقييم
P/E Ratio
0.22
P/B Ratio0.02
EV/EBITDA0.04
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.55% | Revenue Growth (3Y) | 4.46% |
| Earnings Growth (1Y) | -17.20% | Earnings Growth (3Y) | -9.23% |
| Revenue Growth (5Y) | 3.07% | Earnings Growth (5Y) | -6.24% |
| Profitability | |||
| Revenue (TTM) | 225.42B | Net Income (TTM) | 14.10B |
| ROE | 7.82% | ROA | 5.46% |
| Gross Margin | 51.97% | Operating Margin | 9.19% |
| Net Margin | 6.25% | Free Cash Flow (TTM) | 6.58B |
| ROIC | 7.55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.15 | Current Ratio | 2.53 |
| Interest Coverage | 143.84 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 0.22 | P/B Ratio | 0.02 |
| P/S Ratio | 0.01 | PEG Ratio | -2.82 |
| EV/EBITDA | 0.04 | Dividend Yield | 0.01% |
| Market Cap | 3.09B | Enterprise Value | 739.91M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 225.42B | 221.99B | 206.60B | 205.13B | 199.73B |
| Net Income | 14.10B | 17.03B | 17.11B | 23.44B | 18.24B |
| EPS (Diluted) | 42.44 | 50.61 | 50.82 | 69.13 | 53.56 |
| Gross Profit | 117.16B | 111.35B | 103.27B | 106.73B | 100.05B |
| Operating Income | 20.71B | 19.59B | 21.12B | 30.99B | 27.10B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 258.28B | 233.23B | 216.73B | 210.20B | 193.03B |
| Total Liabilities | 76.98B | 52.15B | 49.12B | 53.82B | 54.04B |
| Shareholders' Equity | 179.55B | 181.08B | 167.60B | 156.38B | 138.99B |
| Total Debt | 26.08B | 654.00M | 441.00M | 359.00M | 404.00M |
| Cash & Equivalents | 28.43B | 36.13B | 43.99B | 60.10B | 44.36B |
| Current Assets | 183.09B | 184.33B | 172.50B | 171.88B | 156.14B |
| Current Liabilities | 72.30B | 49.90B | 46.57B | 50.80B | 50.61B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#216 of 820
#425 of 708
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026